Literature DB >> 3665006

Results of surgery for hypertrophic obstructive cardiomyopathy.

W G Williams1, E D Wigle, H Rakowski, J Smallhorn, J LeBlanc, G A Trusler.   

Abstract

Between 1971 and March 1986, 61 patients underwent surgery for hypertrophic obstructive cardiomyopathy. Age at operation varied from 3.5 to 76 years (mean 38). The standard approach was a generous transaortic myectomy. One-quarter of the patients underwent concomitant repair of associated lesions. There was one operative and two late deaths, for an actuarial 5 years survival 93% (+/- 8%). Average follow-up is 3 years per patient. Sixty-four percent of these patients are asymptomatic and another 30% were in New York Heart Association class II. Persistent symptoms were usually related to arrhythmias. Early atrioventricular block did not occur, but two patients were paced for complex arrhythmias 3 and 4 years after surgery. Hemodynamic studies (n = 22), two-dimensional echocardiographic (n = 47), and Doppler assessments (n = 23) demonstrated a left ventricular outflow tract pressure gradient of 70 and 14 mm Hg before and after surgery, respectively, left ventricular diastolic pressure of 18 and 14 mm Hg, percent of patients with mitral regurgitation of 70% and 30%, percent of patients with systolic anterior motion of 100% and 35%, and percent of patients with aortic insufficiency of 9% and 49%. Eight-six percent of the patients catheterized had no resting obstruction. Subaortic myectomy produces symptomatic improvement by reducing the left ventricular outflow tract pressure gradient, mitral regurgitation, and left ventricular end-diastolic pressure, and probably improves longevity.

Entities:  

Mesh:

Year:  1987        PMID: 3665006

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Mitral annular reconstruction with anterior leaflet flip-over in concomitant surgery for mitral regurgitation associated with extensive posterior annular calcification and hypertrophic obstructive cardiomyopathy.

Authors:  Hiroshi Okamoto; Akinori Tamenishi; Yutaka Itoh; Takao Niimi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-02

2.  Hypertrophic obstructive cardiomyopathy associated with mitral regurgitation due to infective endocarditis.

Authors:  M Ninomiya; S Takamoto; Y Kotsuka; T Ohtsuka; K Ueno
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-12

Review 3.  Hypertrophic cardiomyopathy: management issues in the new millennium.

Authors:  Rajesh Thaman; Sami Firoozi; M S Hamid; William J McKenna
Journal:  Curr Cardiol Rep       Date:  2002-05       Impact factor: 2.931

Review 4.  Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: a narrative review.

Authors:  Sarah A Guigui; Christian Torres; Esteban Escolar; Christos G Mihos
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

Review 5.  Percutaneous transluminal septal myocardial ablation.

Authors:  D N Rubin; E M Tuzcu; H M Lever
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 3.955

Review 6.  Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy.

Authors:  Angelos G Rigopoulos; Hubert Seggewiss
Journal:  Curr Cardiol Rev       Date:  2016

7.  Left ventricular remodeling following septal myectomy in hypertrophic obstructive cardiomyopathy.

Authors:  Tsuyoshi Yamabe; Jonathan Ginns; Vijay Vedula; Jay S Leb; Yuichi J Shimada; Shepard D Weiner; Hiroo Takayama
Journal:  JTCVS Open       Date:  2022-06-27

8.  Hypertrophic Cardiomyopathy in a Young Adult with RV Aneurysm: Report of a Rare Finding and Review of the Literature.

Authors:  Ahmed M Abdel-Razek; Leonard Y Lee; Robert Tozzi
Journal:  Heart Views       Date:  2011-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.